Study guide
10.1 Intravitreal Injection Protocol, Antisepsis & Complication Checks
IJCAHPO Certified Retina Technician CRT
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview: Current CRT Requirements & Blueprint
Exam Overview: Current Requirements, Scope & Study Plan
2 Chapter 1: History Taking, Triage & Clinical Documentation
1.1 Comprehensive Ophthalmic & Medical History for Retina Patients 1.2 Telephone Triage, Urgent Symptoms & Emergency Scheduling 1.3 Scribing, Electronic Health Records & Retinal Billing Codes
3 Chapter 2: Visual Assessment & Low Vision Rehabilitation
2.1 Standardized Visual Acuity Testing & Optotypes 2.2 Sub-Chart Acuity Protocols: CF, HM, LP, and NLP 2.3 Low Vision Definitions, Optical Devices & Patient Counseling
4 Chapter 3: Pupil Assessment & Visual Field Testing
3.1 Pupillary Examination & Relative Afferent Pupillary Defect 3.2 Confrontation Fields & Automated Perimetry in Retina 3.3 Amsler Grid Testing & Metamorphopsia Monitoring
5 Chapter 4: Tonometry & Ocular Motility
4.1 Goldmann Applanation & Handheld Tonometry Techniques 4.2 Tonometer Disinfection, Calibration & Post-Procedure IOP Monitoring 4.3 Ocular Motility Assessment, Strabismus & Alignment Testing
6 Chapter 5: Diagnostic Ophthalmic Ultrasound
5.1 Ophthalmic B-Scan Echography for Posterior Segment Pathology 5.2 Standardized A-Scan Echography & Optical Biometry
7 Chapter 6: Slit Lamp, Electrophysiology & Supplemental Testing
6.1 Slit Lamp Biomicroscopy, Illumination & Fundus Lenses 6.2 Color Vision Assessment & Hertel Exophthalmometry 6.3 Ophthalmic Electrophysiology: ERG, VEP, and EOG
8 Chapter 7: Ophthalmic Microbiology & Infection Control
7.1 Ocular Pathogens & Routes of Disease Transmission 7.2 Clinical Asepsis, Universal Precautions & Vitreous Specimen Collection
9 Chapter 8: General Retinal Pharmacology & Therapeutics
8.1 Ocular Drug Delivery Methods & Routes of Administration 8.2 Mydriatics, Cycloplegics & Diagnostic Ophthalmic Dyes 8.3 Anesthetics, Glaucoma Agents & Prescription Verification
10 Chapter 9: Anti-VEGF Therapies, Steroids & Retinal Toxicity
9.1 Anti-VEGF Agents & Neovascular Retinal Diseases 9.2 Corticosteroids, Sustained-Release Implants & AREDS Supplements 9.3 Systemic Medication Retinal Toxicity & Plaquenil Screening
11 Chapter 10: Surgical Assisting & Intravitreal Procedures
10.1 Intravitreal Injection Protocol, Antisepsis & Complication Checks 10.2 Retinal Laser Therapy Modalities & Laser Safety Protocols 10.3 Surgical Instrument Handling, Tray Setup & Sterilization
12 Chapter 11: Patient Services, Education & Clinical Care
11.1 Patient Education, Chronic Disease Counseling & Treatment Adherence 11.2 Special Needs Accommodations, Patient Diversity & Interpersonal Skills 11.3 Ophthalmic Emergencies, First Aid & Clinical Care Coordination 11.4 Clinic Operations, Research Support, Forms & Referrals
13 Chapter 12: General Ocular Anatomy & Retinal Physiology
12.1 Ocular Anatomy, Orbit & Posterior Segment Architecture 12.2 Ten Retinal Layers, Photoreceptors & Macular Anatomy 12.3 Ocular Blood Supply, Microcirculation & Vitreoretinal Interface 12.4 Body Systems, Ocular Adnexa & Medical Terminology
14 Chapter 13: Retinal Pathology & Systemic Disease Manifestations
13.1 Age-Related Macular Degeneration & Retinal Vascular Occlusions 13.2 Diabetic Retinopathy & Systemic Diseases Affecting the Retina 13.3 Peripheral Retinal Degenerations, Tears & Detachments
15 Chapter 14: Ophthalmic Optics & Lensometry
14.1 Principles of Ophthalmic Optics & Refraction 14.2 Manual & Automated Lensometry Techniques
16 Chapter 15: Fundus Photography & Ophthalmic Angiography
15.1 Fundus Photography Techniques & Fundus Autofluorescence 15.2 Fluorescein Angiography Principles, Phases & Image Interpretation 15.3 Indocyanine Green Angiography & Angiographic Complication Management
17 Chapter 16: Optical Coherence Tomography (OCT & OCT-A)
16.1 OCT Principles, Scan Acquisition & Artifact Recognition 16.2 Structural OCT Interpretation: Retinal Fluid & Biomarkers 16.3 Optical Coherence Tomography Angiography (OCT-A) Principles & Flow
18 Chapter 17: Equipment Maintenance, Ethics & Regulatory Compliance
17.1 Equipment Maintenance, Calibration Schedules & Clinic Safety 17.2 Medical Ethics, Scope of Practice & Informed Consent 17.3 Patient Privacy, HIPAA Standards & Hazardous Waste Disposal
10.1 Intravitreal Injection Protocol, Antisepsis & Complication Checks
Key Takeaways Explain This Topic AI
Use two identifiers and reconcile the ordered eye, medication, concentration, dose, route, expiration, lot, consent status, allergies, and time-out before preparation.
Povidone-iodine ocular antisepsis is central to infection prevention; any alternative, concentration, and contact time must come from the current protocol and product instructions.
Injection-site distance and needle technique depend on lens status, age, anatomy, device or drug instructions, and the licensed practitioner's method; do not impose one universal number.
Profound immediate visual loss, severe pain, absent retinal-artery perfusion, or another major change is an immediate stop-and-notify event; the physician directs examination and treatment.
Discharge instructions are procedure- and clinic-specific and must distinguish expected surface irritation from warning symptoms without inventing universal water, activity, or medication restrictions.
Last updated: September 2026
Intravitreal Injection Assisting
An intravitreal injection places medication into the vitreous cavity. The licensed practitioner performs the injection and makes diagnostic and treatment decisions. The technician's responsibility is to make the ordered procedure traceable, protect asepsis, prepare authorized supplies, observe the patient, and close the loop on instructions.
Pre-procedure verification
Use two patient identifiers. Reconcile the schedule, order, consent or authorization status, patient statement, and medication label. Confirm:
- right eye, left eye, or bilateral plan;
- exact medication, concentration, dose, route, and formulation;
- expiration, lot, package integrity, and storage status;
- allergies and the reaction actually experienced;
- recent symptoms, procedures, pressure issues, and clinician-requested measurements;
lens status or other anatomy when it affects the planned technique.
Any laterality, product, dose, or documentation mismatch stops preparation until the team resolves it. Never alter an order to make records agree.
Medication handling
Use medication supplied or prepared through the approved pharmacy and clinic process. Maintain required refrigeration and light protection. If storage limits were exceeded, quarantine the product and obtain an authorized stability determination; appearance alone cannot establish potency or sterility.
Inspect the syringe or vial, verify volume without introducing contamination, and label every prepared syringe immediately. Do not pool, split, substitute, dilute, or transfer products unless the authorized procedure specifically permits it. Follow single-dose and beyond-use instructions.
Antisepsis and field protection
Hand hygiene, mask practices, clean-lane preparation, eyelid and lash isolation, and ocular-surface antisepsis follow the current injection protocol. Povidone-iodine is widely used because it reduces ocular-surface microbial load. Apply the ordered ophthalmic product at the specified sites and allow the validated contact time. Do not use an alcohol-containing skin preparation on the eye.
If a patient reports iodine, contrast, or shellfish allergy, clarify the substance, route, symptoms, and treatment. Shellfish allergy does not establish povidone-iodine allergy. The clinician decides whether a true prior reaction requires another approach. Aqueous chlorhexidine is not interchangeable with common skin products and must never be improvised.
Keep lashes, lid margin, fingers, talking droplets, bottle tips, and nonsterile equipment away from the prepared site and sterile components. Announce and correct any break.
Site and technique
The pars plana entry site is selected by the practitioner based on lens status, age, anatomy, prior surgery, medication or implant instructions, and technique. Common adult teaching ranges differ for phakic and pseudophakic eyes, but one measurement is not universal. The technician provides the approved caliper or device and does not independently choose the site, needle angle, or treatment eye.
Immediate observation
Follow protocol for gross vision, symptoms, pressure, or perfusion checks. A temporary floater or mild surface irritation may occur, but do not normalize profound darkness, marked pressure pain, nausea, absent arterial perfusion, severe inflammation, or a significant vision change. Notify the physician immediately. The clinician determines whether observation, medication, paracentesis, imaging, or another action is required.
If the patient develops breathing difficulty, hypotension, rapidly progressive swelling, or a multisystem reaction, activate the emergency response and follow the authorized medication protocol.
Documentation and discharge
Record patient and eye, product, dose, lot and expiration when required, preparation source, administration time, personnel, antisepsis, immediate checks, adverse events, and instructions. Use the clinician-approved discharge sheet. Warning symptoms commonly include increasing pain, redness, photophobia, discharge, or declining vision. Activity, water exposure, drops, driving, patching, and follow-up timing vary; give the actual ordered instructions rather than a memorized restriction.
Ask the patient to teach back whom to call and when. A reliable injection visit ends with traceable medication, intact documentation, and a clear emergency pathway.
Time-out, observation, and event documentation
Immediately before the procedure, the team confirms two identifiers, treated eye, medication, dose and route, indication stated in the order, consent status, allergies or prior reactions, and any required lot or expiration data. Laterality marking and the verbal time-out must agree. If the chart, patient, prepared syringe, and time-out do not match, stop and preserve the discrepancy for resolution; familiarity with a recurring patient is not a substitute for verification.
After the injection, perform only ordered checks and observe for the protocol-defined interval. A transient floater or surface irritation may occur, but a technician should not normalize increasing pain, marked redness, photophobia, discharge, a major vision change, or systemic symptoms. Give the approved written instructions and contact route, use teach-back, and document the medication, eye, time, personnel, tolerance, checks, education, and disposition. Never add a universal water, antibiotic, patching, or activity rule that is absent from the treating clinician's instructions.